Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanoma
Abstract The prognosis of metastatic melanoma remains poor due to de novo or acquired resistance to immune and targeted therapies. Previous studies have shown that melanoma cells have perturbed metabolism and that cellular metabolic pathways represent potential therapeutic targets. To support the di...
Guardado en:
Autores principales: | Cecilie Abildgaard, Salvatore Rizza, Helle Christiansen, Steffen Schmidt, Christina Dahl, Ahmad Abdul-Al, Annette Christensen, Giuseppe Filomeni, Per Guldberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1b24ea4a0dc64c8fbd2d5e8ec70458cd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mitochondrial Metabolism in Melanoma
por: Christina Huang, et al.
Publicado: (2021) -
Metabolic Reprogramming in COVID-19
por: Tao Shen, et al.
Publicado: (2021) -
Metabolic Reprogramming and Renal Fibrosis
por: Xiaoyu Zhu, et al.
Publicado: (2021) -
Intracellular sodium elevation reprograms cardiac metabolism
por: Dunja Aksentijević, et al.
Publicado: (2020) -
Recent Metabolomics Analysis in Tumor Metabolism Reprogramming
por: Jingjing Han, et al.
Publicado: (2021)